A group of investigators led by Cedars-Sinai have developed and successfully tested a new artificial intelligence (AI) method ...

A new pathology tool created at Yale harnesses barcode technology and shows potential for use in cancer diagnoses. The ...

New research suggests previous assumptions about the pathogenesis of spinal muscular atrophy (SMA) are inadequate.

Andrew H. Song, a postdoctoral research fellow at Harvard Medical School, presented his work on applying deep learning tools ...

An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, ...

Ed Schuuring, Senior Clinical Scientist in Molecular Pathology and Professor of Molecular Oncology in the Department of ...

There are many different ways to approach cybersecurity. One of the most effective ways to critically approach cybersecurity ...

A 'deep learning' artificial intelligence model can identify pathology, or signs of disease, in images of animal and human tissue much faster, and often more accurately, than people. The development ...

In patients with AD who have seizures, spatial relationships were observed between the epileptogenic focus and tau and amyloid deposition, as well as neurodegeneration.

An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, according to a new study by scientists at Weill Cornell Medicine.